Drugs / tPA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02315898 | Mar 2018 → Mar 2021 | plastic bronchitis, protein-losing enteropathy | University of Michigan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02315898 ↗ |
| Route | Inhaled | “Enrolled patients with acute plastic bronchitis (fibrin airway casts) will receive inhaled tPA treatment.” NCT02315898 ↗ |